Kathy Hopinkah Hannan

CIK: 0001767813

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (20.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

NLY

ANNALY CAPITAL MANAGEMENT INC

Director

OTIS

Otis Worldwide Corp

Director

DNA

Ginkgo Bioworks Holdings, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

NLY
ANNALY CAPITAL MANAGEMENT INC
Jun 10, 2026
Award(A)
Deferred Stock Units
Direct
8.6K shares-
OTIS
Otis Worldwide Corp
May 27, 2026
Award(A)
Deferred Stock Units
Direct
2.8K shares at avg. $71.79-
DNA
Ginkgo Bioworks Holdings, Inc.
Jun 11, 2025
Exercise(M)
Direct
10.8K shares-
OTIS
Otis Worldwide Corp
May 15, 2025
Award(A)
Deferred Stock Units
Direct
2K shares at avg. $97.86-
NLY
ANNALY CAPITAL MANAGEMENT INC
May 14, 2025
Award(A)
Deferred Stock Units
Direct
9K shares-

		Type	Shares	Price		Ownership
Jun 10, 2026	NLY ANNALY CAPITAL MANAGEMENT INC	Award(A) Deferred Stock Units	8,641	-	-	Direct
May 27, 2026	OTIS Otis Worldwide Corp	Award(A) Deferred Stock Units	2,758	$71.79	-	Direct
Jun 11, 2025	DNA Ginkgo Bioworks Holdings, Inc.	Exercise(M)	10,822	-	-	Direct
May 15, 2025	OTIS Otis Worldwide Corp	Award(A) Deferred Stock Units	1,993	$97.86	-	Direct
May 14, 2025	NLY ANNALY CAPITAL MANAGEMENT INC	Award(A) Deferred Stock Units	8,961	-	-	Direct

1-5 of 5 transactions

About Hannan Kathy Hopinkah

Hannan Kathy Hopinkah (SEC CIK 0001767813) files insider reports with the SEC as Director of ANNALY CAPITAL MANAGEMENT INC (NLY), Director of Otis Worldwide Corp (OTIS) and Director of Ginkgo Bioworks Holdings, Inc. (DNA).

Signal8 holds 5 ownership filings by Hannan Kathy Hopinkah, all Form 4s, filed between May 15, 2025 and Jun 12, 2026. Those filings report 5 transactions, from May 14, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hannan Kathy Hopinkah's filings is in NEW YORK, NY.

Recent filings by Hannan Kathy Hopinkah

Jun 10, 2026: Grant or award of NLY derivative securities (Form 4, code A).
May 27, 2026: Grant or award of OTIS derivative securities (Form 4, code A).
Jun 11, 2025: Option exercise of DNA shares (Form 4, code M).
May 15, 2025: Grant or award of OTIS derivative securities (Form 4, code A).
May 14, 2025: Grant or award of NLY derivative securities (Form 4, code A).

Other insiders filing for ANNALY CAPITAL MANAGEMENT INC (NLY)

Finkelstein David L, CEO and Co-CIO
Hamilton Thomas Edward, Director
Laguerre Martin, Director
VOTEK GLENN, Director
Laroche Manon, Director
Williams Vicki, Director

How to read Form 4 transaction codes